Health ❯Pharmaceuticals

Weight Loss Drugs

Ozempic Semaglutide Wegovy GLP-1 Agonists Clinical Trials Tirzepatide GLP-1 Drugs GLP-1 Receptor Agonists Novo Nordisk Eli Lilly

Ozempic and Wegovy Users Face Dental Decay and Unusual Scent Cravings

Experts call for proactive hydration with regular dental check-ups following reports of semaglutide-linked oral damage.

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

WW International Files for Bankruptcy, Signaling End of Iconic WeightWatchers Era

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

Janelle Rohner Issues Refunds After GLP-1 Weight Loss Disclosure

Eli Lilly Sues Strive and Empower Over Unapproved Tirzepatide Products

Ekta Kapoor's Instagram Post Fuels Speculation About Ram Kapoor's Weight Loss Claims

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

U.S. Obesity Rates Decline for First Time in Over a Decade

Scams and Counterfeits Exploit Demand for Weight-Loss Drugs

Al Roker Supports Use of Weight Loss Drugs, Citing Unique Challenges of Food Addiction

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Semaglutide Shows Promising Results in Reducing Knee Arthritis Pain in Obese Patients

UK Regulators Warn Against Misuse of Weight-Loss Injections

Bank of Canada Expected to Announce Significant Rate Cut

Senator Warren Urges FTC to Scrutinize Novo Holdings' $16.5B Catalent Acquisition

CDC Reports Stagnation in U.S. Obesity Rates, but Severe Obesity Continues to Rise

23andMe Board Resigns Amid CEO's Privatization Push